Results
|
|
1.
|
|
|
|
2.
|
Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. [electronic resource] by
- Ueland, Thor
- Kleveland, Ola
- Michelsen, Annika E
- Wiseth, Rune
- Damås, Jan Kristian
- Holven, Kirsten B
- Aukrust, Pål
- Gullestad, Lars
- Yndestad, Arne
- Halvorsen, Bente
Producer: 20190719
In:
International journal of cardiology vol. 274
Availability: No items available.
|
|
|
3.
|
Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. [electronic resource] by
- Holte, Espen
- Kleveland, Ola
- Ueland, Thor
- Kunszt, Gabor
- Bratlie, Marte
- Broch, Kaspar
- Michelsen, Annika E
- Bendz, Bjørn
- Amundsen, Brage H
- Aakhus, Svend
- Damås, Jan Kristian
- Gullestad, Lars
- Aukrust, Pål
- Wiseth, Rune
Producer: 20170919
In:
Heart (British Cardiac Society) vol. 103
Availability: No items available.
|
|
|
4.
|
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. [electronic resource] by
- Kleveland, Ola
- Kunszt, Gabor
- Bratlie, Marte
- Ueland, Thor
- Broch, Kaspar
- Holte, Espen
- Michelsen, Annika E
- Bendz, Bjørn
- Amundsen, Brage H
- Espevik, Terje
- Aakhus, Svend
- Damås, Jan Kristian
- Aukrust, Pål
- Wiseth, Rune
- Gullestad, Lars
Producer: 20180405
In:
European heart journal vol. 37
Availability: No items available.
|
|
|
5.
|
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction. [electronic resource] by
- Kleveland, Ola
- Ueland, Thor
- Kunszt, Gabor
- Bratlie, Marte
- Yndestad, Arne
- Broch, Kaspar
- Holte, Espen
- Ryan, Liv
- Amundsen, Brage H
- Bendz, Bjørn
- Aakhus, Svend
- Espevik, Terje
- Halvorsen, Bente
- Mollnes, Tom E
- Wiseth, Rune
- Gullestad, Lars
- Aukrust, Pål
- Damås, Jan Kristian
Producer: 20190311
In:
International journal of cardiology vol. 271
Availability: No items available.
|
|
|
6.
|
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction. [electronic resource] by
- Orrem, Hilde L
- Nilsson, Per H
- Pischke, Søren E
- Kleveland, Ola
- Yndestad, Arne
- Ekholt, Karin
- Damås, Jan K
- Espevik, Terje
- Bendz, Bjørn
- Halvorsen, Bente
- Gregersen, Ida
- Wiseth, Rune
- Andersen, Geir Ø
- Ueland, Thor
- Gullestad, Lars
- Aukrust, Pål
- Barratt-Due, Andreas
- Mollnes, Tom E
Producer: 20190930
In:
Frontiers in immunology vol. 9
Availability: No items available.
|
|
|
7.
|
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI). [electronic resource] by
- Anstensrud, Anne Kristine
- Woxholt, Sindre
- Sharma, Kapil
- Broch, Kaspar
- Bendz, Bjørn
- Aakhus, Svend
- Ueland, Thor
- Amundsen, Brage H
- Damås, Jan Kristian
- Hopp, Einar
- Kleveland, Ola
- Stensæth, Knut Haakon
- Opdahl, Anders
- Kløw, Nils-Einar
- Seljeflot, Ingebjørg
- Andersen, Geir Øystein
- Wiseth, Rune
- Aukrust, Pål
- Gullestad, Lars
Producer: 20210201
In:
Open heart vol. 6
Availability: No items available.
|